Abstract
In vitro studies have shown that production of the vasoconstrictor endothelin-1 (ET) is inhibited by NO in porcine aorta (Boulanger & Lüscher, 1990) while in vivo studies have shown that the increase in total peripheral resistance following nitric oxide synthase (NOS) inhibition in anesthetized rats is blunted by blockade of endothelin receptors (Nafrialdi et al., 1994; Richard et al., 1995). In order to assess the role of endothelin in the regulation of resting vascular tone in skeletal muscle, it was first necessary to establish that we could effectively inhibit the vasoconstrictor actions of endothelin in our experimental preparation. Endothelin-1 binds to both ETA receptors on vascular smooth muscle producing vasoconstriction (Barnes, 1994) and to ETB receptors on endothelial cells to induce transient vasodilation through stimulation of NO production (Fujitani et al., 1993; Sakurai et al., 1992). The contribution of ETB receptors in the vasoconstrictor response to ET is minimal, but some studies have demonstrated that the ETA receptor antagonists BQ123 and FR139317 were unable to fully prevent or reverse the vasoconstrictor effect of endothelin in (Bird & Waldron, 1993; McMurdo et al., 1993). Because the dilatory action of ET is transient, we elected to focus on the vasoconstrictor action of ET.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnes, P.J. Endothelins and pulmonary disease. J. Appl. Physiol. 77:1051–1059, 1994.
Bird, J.E. and T.L. Waldron. Incomplete inhibition of endothelin-1 pressor effects by an endothelin ETA receptor anatagonist. Eur. J. Pharmacol. 240:295–298, 1993.
Boulanger, C. and T.F. Lüscher. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85:587–590, 1990.
Clozel, M. and J.-P. Clozel. Effects of endothelin on regional blood flows in squirrel monkeys. J. Pharmacol. Expt. Ther. 250:1125–1131, 1989.
Donicker, J.E., C. Hanet, A. Berbinschi, L. Galanti, A. Robert, H. VanMechelen, H. Pouleur and J-M. Ketelslegers. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circ. 84:2476–2484, 1991.
Fujitani, Y., H. Ueda, T. Okada, Y. Urade and H. Karaki. A selective agonist of endothelin Type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta. J. Pharmacol. Expt. Ther. 267:683–689, 1993.
Given, M.B., R.F. Lowe, H. Lippton, A.L. Hyman, G.E. Sander and T.D. Giles. Hemodynamic actions of endothelin in conscious and anesthetized dogs. Peptides 10:41–44, 1989.
Ihara, M., K. Noguchi, T. Saeki, T. Fukuroda, S. Tsuchida, S. Kimura, T. Fukami, K. Ishikawa, M. Nishikibe and M. Yano. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 50:247–255, 1992.
Kubes, P., M. Melinyshyn, K. Nesbitt, S.M. Cain and C.K. Chapter. Participation of α2-adrenergic receptors in neural vascular tone of canine skeletal muscle. Am. J. Physiol. 262:H1705–H1710, 1992.
Lerman, K., E.K. Sandok, F.L. Hildebrand and J.C. Burnett. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circ. 85:1894–1898, 1992.
McMurdo, L., R. Corder, C. Thiemermann and J.R. Vane. Incomplete inhibition of the pressor effect of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor substance. Br. J. Pharmacol. 108:557–561, 1993.
Nafrialdi, N., B. Jover and A. Mimran. Endogenous vasoactive systems and the pressor effect of acute Nω-nitro-L-arginine methyl ester administration. J. Cardiovasc. Pharmacol. 23:765–771, 1994.
Richard, V., M. Hogie, M. Clozel, B. Löffler and C. Thuillez. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circ. 91:771–775, 1995.
Rogerson, M.E., H.S. Cairns, L.D. Fairbanks, J. Westwick and G.H. Neild. Endothelin-1 in the rabbit: interactions with cyclo-oxygenase and NO-synthase products. Br. J. Pharmacol. 108:838–843, 1993.
Sakurai, T., M. Yanagisawa and T. Masaki. Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 13:103–108, 1992.
Warner, T.D., G.H. Allcock and J.R. Vane. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonist, BQ-123 and PD-145065. Br. J. Pharmacol. 112:207–213, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
King-VanVlack, C.E., Curtis, S.E., Mewburn, J.D., Cain, S.M., Chapler, C.K. (1997). Endothelial and Sympathetic Regulation of Vascular Tone in Canine Skeletal Muscle. In: Nemoto, E.M., et al. Oxygen Transport to Tissue XVIII. Advances in Experimental Medicine and Biology, vol 411. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5865-1_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5865-1_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7689-7
Online ISBN: 978-1-4615-5865-1
eBook Packages: Springer Book Archive